title: [Strategies for effective control of arterial hypertension in Spain. Consensus document].
abstract: Blood pressure (BP) control is inadequate among treated hypertensive patients in Spain. Control rates are lower than 40% of all treated patients and the cause of this problem is multifactorial. Despite the fact that possible solutions to this problem have been repeatedly suggested by expert groups along the last 10 years, BP control rates are still low. This fact have a negative impact on cardiovascular morbidity and mortality of patients with hypertension. The aim of the present document has been to achieve a consensus on effective specific measures in order to improve hypertension control rates in Spain. These measures involve health care professionals (physicians, nurses, pharmaceutics), health care authorities and patients. The document summarizes the consensus conference of several scientific societies involved in cardiovascular medicine in five group of measures: a) improvement of the methodology of office BP measurement; b) improvement of compliance to treatment by patients; c) clarification of pressure targets to be achieved in hypertensive patients; d) optimization of life style modifications and pharmacological treatment of hypertension; and e) continuous medical education. The document emphasize life style changes as a crucial aspect to be implemented in all patients. These changes have a beneficial impact on pressure reduction, contribute to a better control of associated cardiovascular risk factors, and increase the effectiveness of antihypertensive drugs. Health care professionals should base their clinical practice on the recommendations of guidelines in order to modify their therapeutic attitudes in patients whose targets have not been achieved.
authors.affiliation: Unidad de Hipertensión Arterial, Instituto de Medicina y Dermatología (IDIBAPS), Hospital Clínico, Universidad de Barcelona, Sociedad Española de Hipertensión (SEH-LELHA), España. acoca@linic.ub.es
authors.forename: A
authors.initials: A
authors.lastname: Coca
authors.forename: P
authors.initials: P
authors.lastname: Aranda
authors.forename: V
authors.initials: V
authors.lastname: Bertomeu
authors.forename: A
authors.initials: A
authors.lastname: Bonet
authors.forename: E
authors.initials: E
authors.lastname: Esmatjes
authors.forename: F
authors.initials: F
authors.lastname: Guillén
authors.forename: J
authors.initials: J
authors.lastname: Hernández-Moreno
authors.forename: J L
authors.initials: JL
authors.lastname: Llisterri
authors.forename: R
authors.initials: R
authors.lastname: Marín-Iranzo
authors.forename: C
authors.initials: C
authors.lastname: Megía
authors.forename: L
authors.initials: L
authors.lastname: Rodríguez-Mañas
authors.forename: C
authors.initials: C
authors.lastname: Suárez
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D001795:Blood Pressure Determination; D004502:Education, Medical, Continuing; D006801:Humans; D006973:Hypertension / Q000517:prevention & control*; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D040242:Risk Reduction Behavior; D013030:Spain
chemical_list: D000959:Antihypertensive Agents